Table 1.
Variable | N | Bone present % (#) | Bone absent % (#) | OR | 95% CI | p |
---|---|---|---|---|---|---|
Warfarin use | 195 | 16.7 (5) | 3.6 (6) | 5.30 | 1.59, 17.72 | 0.004 |
African American versus Caucasian race | 192 | 13.3 (4) | 2.5 (4) | 6.08 | 1.56, 23.7 | 0.006 |
Left ventricular hypertrophy | 165 | 84.6 (22) | 95.0 (132) | 0.29 | 0.083, 1.01 | 0.052 |
Diabetes mellitus | 195 | 16.7 (5) | 33.3 (55) | 0.40 | 0.15, 1.07 | 0.069 |
Female sex | 195 | 26.7 (8) | 44.2 (73) | 0.46 | 0.20, 1.07 | 0.072 |
Mitral regurgitation | 166 | 59.3 (16) | 74.8 (104) | 0.49 | 0.21, 1.14 | 0.098 |
Hypertension | 195 | 40.0 (12) | 53.9 (89) | 0.57 | 0.26,1.24 | 0.160 |
Current cigarette smoking | 194 | 6.7 (2) | 16.5 (27) | 0.36 | 0.00, 1.46 | 0.167 |
Statin use | 195 | 3.3 (1) | 11.5 (19) | 0.26 | 0.00, 1.62 | 0.174 |
Coronary artery disease | 195 | 73.3 (22) | 61.2 (101) | 1.74 | 0.74, 4.07 | 0.206 |
Carotid artery disease | 195 | 6.7 (2) | 15.2 (25) | 0.4 | 0.00, 1.62 | 0.216 |
Glucocorticoid use | 194 | 3.3 (1) | 7.3 (12) | 0.44 | 0.00, 2.75 | 0.422 |
Estrogen replacement therapy | 81 | 0 (0) | 6.17 (5) | 0 | 0.00, 7.31 | 0.445 |
Bicuspid valve (versus tricuspid) | 195 | 26.7 (8) | 20.9 (34) | 1.40 | 0.58, 3.32 | 0.479 |
Peripheral artery disease | 195 | 10.0 (3) | 7.3 (12) | 1.42 | 0.40, 5.03 | 0.606 |
Bisphosphonate use | 194 | 0 (0) | 0.61 (1) | 0 | 0 | 0.669 |
Aortic valve insufficiency | 157 | 66.7 (16) | 66.2 (88) | 1.02 | 0.41, 2.51 | 0.962 |